HF
DXCM icon

HRT Financial’s DexCom DXCM Stock Holding History

HRT Financial’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.06M Buy
45,400
+29,900
+193% +$1.99M 0.01% 1448
2026
Q1 		$973K Sell
15,500
-12,000
-44% -$836K ﹤0.01% 2079
2025
Q4 		$1.82M Buy
27,500
+5,100
+23% +$330K 0.01% 1366
2025
Q3 		$1.51M Buy
+22,400
New +$1.77M 0.01% 1311
2025
Q2 		– Sell
-3,300
Closed -$225K – 2831
2025
Q1 		$225K Buy
+3,300
New +$269K ﹤0.01% 1940
2023
Q4 		– Sell
-16,000
Closed -$1.49M – 2473
2023
Q3 		$1.49M Buy
+16,000
New +$1.8M 0.01% 764
2023
Q1 		– Sell
-6,800
Closed -$770K – 2641
2022
Q4 		$770K Buy
+6,800
New +$747K 0.01% 1124
2022
Q2 		– Sell
-29,600
Closed -$3.79M – 3094
2022
Q1 		$3.79M Buy
29,600
+13,600
+85% +$1.49M 0.03% 371
2021
Q4 		$2.15M Sell
16,000
-27,600
-63% -$3.97M 0.01% 621
2021
Q3 		$5.96M Buy
+43,600
New +$5.5M 0.04% 274

Other funds holding DXCM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HRT Financial's DXCM Position: Q2 2026 in Review

HRT Financial opened a new position in DexCom (DXCM) in Q2 2026: 12,870 shares worth $866K. The stake represents ﹤0.01% of the portfolio and ranks #2256 among its holdings. This is a return to the name: HRT Financial previously reported a position in DXCM as recently as Q4 2025.

HRT Financial first reported a position in DXCM in Q3 2018 and has held it in 15 quarters since. The position peaked at $22.3M in Q4 2024. 976 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • HRT Financial held 12,870 shares of DexCom worth $866K as of Q2 2026.
  • DexCom was a new HRT Financial position in Q2 2026.
  • DexCom made up ﹤0.01% of HRT Financial's portfolio in Q2 2026, its #2256 holding.
  • HRT Financial first reported a position in DexCom in Q3 2018 and has held it in 15 quarters since.
  • HRT Financial's DexCom position peaked at $22.3M in Q4 2024.
  • 976 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.